PharmEasy

Mumbai, India Founded: 2015 • Age: 11 yrs
Provider of an online pharmacy and healthcare platforms
Request Access

About PharmEasy

PharmEasy is a company based in Mumbai (India) founded in 2015 by Harsh Parekh, Hardik Dedhia, and Dhaval Shah.. PharmEasy has raised $688.41 million across 11 funding rounds from investors including MediBuddy, Bessemer Venture Partners and Avendus. PharmEasy has completed 1 acquisition, including Medlife. PharmEasy offers products and services including Medicine Delivery, Lab Tests, and Doctor Consultations. PharmEasy operates in a competitive market with competitors including Tata 1mg, Netmeds, Truemeds, MedPlus and SastaSundar, among others.

  • Headquarter Mumbai, India
  • Founders Harsh Parekh, Hardik Dedhia, Dhaval Shah
  • Stage Unicorn
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $688.41 M (USD)

    in 11 rounds

  • Latest Funding Round
    $193 M (USD), Debt – Conventional

    Sep 16, 2025

  • Investors
    MediBuddy

    & 39 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PharmEasy

PharmEasy offers a comprehensive portfolio of products and services, including Medicine Delivery, Lab Tests, and Doctor Consultations. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Online service for ordering and delivering medicines to users.

Platform for booking and accessing various health tests remotely.

Virtual platform for remote medical advice and consultations.

People of PharmEasy
Headcount 1000-5000
Employee Profiles 47
Employee Profiles
People
Santosh Pawar
VP, Engineering
People
Ram Cv
CFO
People
Abhishek Ray
Head-business Finance And Commercial-api Group [pharma+b2c Diagnostics]
People
Nidhi Lashkari
Director Engineering

Unlock access to complete

Funding Insights of PharmEasy

PharmEasy has successfully raised a total of $688.41M across 11 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $193 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 11
  • Last Round Debt – Conventional — $193.0M
  • First Round

    (01 Jun 2015)

  • Investors Count 40
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2025 Amount Debt – Conventional - PharmEasy Valuation 360 One
May, 2022 Amount Series F - PharmEasy Valuation

investors

GSV
Feb, 2022 Amount Series F - PharmEasy Valuation

investors

GSV
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in PharmEasy

PharmEasy has secured backing from 40 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include MediBuddy, Bessemer Venture Partners and Avendus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Venture capital firm focused on early-stage companies
Founded Year Domain Location
An investment platform is provided for diverse sectors and geographies.
Founded Year Domain Location
Fund of funds focused on pre-seed and seed-stage companies
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by PharmEasy

PharmEasy has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Medlife. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Provider of an online pharmacy for medications
2014
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - PharmEasy

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pharmeasy Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PharmEasy

PharmEasy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tata 1mg, Netmeds, Truemeds, MedPlus and SastaSundar, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of an online pharmacy with doctor listing and teleconsultation services
domain founded_year HQ Location
Provider of an online store for medicines and healthcare products
domain founded_year HQ Location
Provider of an online pharmacy and telehealth platform
domain founded_year HQ Location
Medicines and health products are retailed through pharmacy outlets.
domain founded_year HQ Location
An online marketplace for healthcare products is operated.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pharmeasy

Frequently Asked Questions about PharmEasy

When was PharmEasy founded?

PharmEasy was founded in 2015.

Where is PharmEasy located?

PharmEasy is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Is PharmEasy a funded company?

PharmEasy is a funded company, having raised a total of $688.41M across 11 funding rounds to date.

What does PharmEasy do?

Provider of an online pharmacy and healthcare platforms. It offers a wide range of pharmaceutical products, healthcare and wellness items, over-the-counter (OTC) products, ayurvedic and homeopathic medicines, medical devices, and lab test.

Who are the top competitors of PharmEasy?

PharmEasy's top competitors include Tata 1mg, SastaSundar and MedPlus.

What products or services does PharmEasy offer?

PharmEasy offers Medicine Delivery, Lab Tests, and Doctor Consultations.

How many acquisitions has PharmEasy made?

PharmEasy has made 1 acquisition, including Medlife.

Who are PharmEasy's investors?

PharmEasy has 40 investors. Key investors include MediBuddy, Bessemer Venture Partners, Avendus, Timesgroup, and TPG.

What is PharmEasy's valuation?

The valuation of PharmEasy is $1.04B as of Feb 2021.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available